| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Options Exercise | $2.01M | +54.6K | +22.97% | $36.81 | 293K | Nov 9, 2021 | Direct | |
| transaction | XYL | Common Stock | Sale | -$7.26M | -54.6K | -18.68% | $132.91 | 238K | Nov 9, 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -54.6K | -49.25% | $0.00 | 56.3K | Nov 9, 2021 | Common | 54.6K | $36.81 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021. |
| F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 26,858 Shares were executed at a range of prices from $131.93 to $132.92. 27,785 Shares were executed at a range of prices from 132.93 to $133.75. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| F3 | These options are fully vested and exercisable. |